Agile Therapeutics, Inc.
Dermal Delivery Device

Last updated:

Abstract:

A transdermal drug delivery device is disclosed. Over an extended wear period, the device causes cumulative moderate irritation plus significant irritation of less than 5% and/or achieves a meaningful degree of detachment over a seven day period of less than 20%.

Status:
Application
Type:

Utility

Filling date:

19 Oct 2020

Issue date:

4 Feb 2021